We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Abbott Laboratories | NYSE:ABT | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 106.17 | 34 | 11:52:03 |
From May 2019 to May 2024
By Josh Beckerman
The U.S. Food and Drug Administration has identified an Abbott Laboratories (ABT) June recall of certain Ellipse Implantable Cardioverter Defibrillators as a Class I recall.
The FDA said 108 devices were recalled in the U.S. because of a faulty manufacturing process that caused some wires to be partially exposed.
Abbott isn't aware of any reports of device failure in implanted devices, the FDA said.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
August 05, 2019 19:26 ET (23:26 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Abbott Laboratories Chart |
1 Month Abbott Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
